The significance of countable and treatable metastatic liver disease in patients with gallbladder carcinoma after curative‐intent surgery: A 10‐year experience in China

Objective Our study was performed to evaluate the significance of countable and treatable metastatic liver disease (CTMLD) in patients with gallbladder carcinoma (GBC) after curative‐intent surgery. Methods Resected GBC patients between September 2010 and January 2021 were reviewed. Comparative anal...

Full description

Saved in:
Bibliographic Details
Published in:Cancer medicine (Malden, MA) MA), 2023-09, Vol.12 (18), p.18503-18515
Main Authors: Lv, Tian‐Run, Liu, Fei, Ma, Wen‐Jie, Hu, Hai‐Jie, Jin, Yan‐Wen, Li, Fu‐Yu
Format: Article
Language:English
Subjects:
Ablation
Cancer
Carcinoma
Chemotherapy
Cholecystectomy
Comparative analysis
Gallbladder
Gallbladder cancer
gallbladder carcinoma
Hepatectomy
Hospitals
Liver diseases
liver metastasis
Lymph nodes
Lymphatic system
Medical prognosis
Metastases
Metastasis
Patients
prognosis
Statistical analysis
Surgery
Survival
Ultrasonic imaging
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective Our study was performed to evaluate the significance of countable and treatable metastatic liver disease (CTMLD) in patients with gallbladder carcinoma (GBC) after curative‐intent surgery. Methods Resected GBC patients between September 2010 and January 2021 were reviewed. Comparative analyses between patients with CTMLD and those without it were performed. A propensity score matching analysis was conducted for further validation. Results A total of 326 resected GBC patients were identified (33 with CTMLD). A significantly higher preoperative CA199 level was detected in those with CTMLD (p = 0.0160). Significantly higher incidences of major hepatectomy (p = 0.0010), lymph node metastasis (p 
ISSN:2045-7634
2045-7634
DOI:10.1002/cam4.6450